AN LU: Open Payments
NPI 1437994704 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,933 in 176 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,198 · 2025 $3,933
Food & beverage: $3,933
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $515 |
| AstraZeneca Pharmaceuticals LP | 15 | $448 |
| Gilead Sciences, Inc. | 12 | $403 |
| Sumitomo Pharma America, Inc. | 25 | $370 |
| ABBVIE INC. | 12 | $368 |
| Verona Pharma, Inc. | 15 | $272 |
| Baxter Healthcare | 5 | $213 |
| Novo Nordisk Inc | 11 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $162 |
| Lilly USA, LLC | 9 | $161 |
Products named: GEMTESA, Ohtuvayre, UBRELVY, AIRSUPRA, OTEZLA, REPATHA, JARDIANCE, MOUNJARO.
Industry payments across VA — which companies pay providers there.
